Alzheimer's Disease

Showing NaN - NaN of 79

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in Worldwide (RO4602522, Placebo, Donepezil)

Completed
  • Alzheimer's Disease
  • Anaheim, California
  • +141 more
May 25, 2017

Alzheimer's Disease, Dementia Trial in Toronto (Cholinesterase Inhibitor, Placebo)

Completed
  • Alzheimer's Disease
  • Dementia
  • Cholinesterase Inhibitor
  • Placebo
  • Toronto, Ontario, Canada
  • +1 more
Apr 26, 2017

Alzheimer's Disease Trial in Worldwide (Placebo, RO5313534)

Completed
  • Alzheimer's Disease
  • Orange, California
  • +66 more
Nov 1, 2016

Alzheimer's Disease, Dementia Trial in Worldwide (EVP-6124)

Terminated
  • Alzheimer's Disease
  • Dementia
  • Phoenix, Arizona
  • +85 more
May 2, 2016

Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)

Terminated
  • Alzheimer's Disease
  • Dementia
  • Drug: EVP-6124
  • Placebo
  • Phoenix, Arizona
  • +81 more
May 2, 2016

Alzheimer's Disease Trial in Worldwide (Avagacestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +63 more
Sep 23, 2015

Alzheimer's Disease Trial in Worldwide (LY450139, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +90 more
Jan 28, 2015

Alzheimer's Disease Trial in Worldwide (ABT-126, )

Completed
  • Alzheimer's Disease
  • Fresno, California
  • +42 more
Oct 24, 2014

Alzheimer's Disease Neuroimaging Initiative Grand Opportunity

Completed
  • Mild Cognitive Impairment
  • Alzheimer's Disease
    • Birmingham, Alabama
    • +54 more
    Sep 15, 2014

    Alzheimer's Disease Trial in Worldwide (BMS-241027, Placebo matching BMS-241027)

    Completed
    • Alzheimer's Disease
    • Anaheim, California
    • +23 more
    Jul 23, 2014

    Alzheimer's Disease, Agitation Trial in Canada, United States (citalopram, )

    Completed
    • Alzheimer's Disease
    • Agitation
    • Los Angeles, California
    • +7 more
    Jun 26, 2014

    Alzheimer's Disease Trial in Austria, Canada, United States (Bapineuzumab)

    Terminated
    • Alzheimer's Disease
    • Birmingham, Alabama
    • +190 more
    Nov 26, 2013

    Alzheimer's Disease Trial in Canada (Memantine, Placebo)

    Terminated
    • Alzheimer's Disease
    • Edmonton, Alberta, Canada
    • +22 more
    Nov 12, 2013

    Alzheimer's Disease Trial in Worldwide (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)

    Completed
    • Alzheimer's Disease
    • Bapineuzumab 0.5 mg/kg
    • +2 more
    • Birmingham, Alabama
    • +250 more
    Oct 30, 2013

    Alzheimer's Disease Trial in Canada, United States (T-817MA, Placebo)

    Completed
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +34 more
    Oct 9, 2013

    Alzheimer's Disease Trial in Canada, Puerto Rico, United States (Dimebon)

    Terminated
    • Alzheimer's Disease
    • Mobile, Alabama
    • +105 more
    Oct 11, 2012

    Alzheimer's Disease Trial in Worldwide (LY2062430, Placebo)

    Completed
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +84 more
    Sep 18, 2012

    Alzheimer's Disease Trial in Canada (Memantine)

    Terminated
    • Alzheimer's Disease
    • Edmonton, Alberta, Canada
    • +32 more
    Jul 26, 2012

    Alzheimer's Disease Trial in Canada, United States (ONO-2506PO)

    Completed
    • Alzheimer's Disease
    • Birmingham, Alabama
    • +86 more
    Jun 12, 2012

    Alzheimer's Disease Trial in Canada, United States (ST101, Placebo)

    Completed
    • Alzheimer's Disease
    • Costa Mesa, California
    • +17 more
    Jun 5, 2012

    Alzheimer's Disease Trial in Canada, United States (ST101, Placebo)

    Completed
    • Alzheimer's Disease
    • Tucson, Arizona
    • +29 more
    Jun 5, 2012

    Alzheimer's Disease Trial in Canada, United States (FK962)

    Terminated
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +83 more
    Jun 6, 2012

    Alzheimer's Disease Trial in Toronto (memantine)

    Completed
    • Alzheimer's Disease
    • Toronto, Ontario, Canada
    • +1 more
    May 24, 2012

    Alzheimer's Disease Trial in Worldwide (Lu AE58054, Placebo)

    Completed
    • Alzheimer's Disease
    • Lu AE58054
    • Placebo
    • East Gosford, Australia
    • +50 more
    Jan 5, 2012

    Alzheimer's Disease, Dementia Trial in Worldwide (Donepezil HCl)

    Completed
    • Alzheimer's Disease
    • Dementia
    • Donepezil hydrochloride
    • Northport, Alabama
    • +41 more
    Mar 31, 2011